These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 29655463)

  • 1. Proteomics for Biomarker Identification and Clinical Application in Kidney Disease.
    Chen L; Su W; Chen H; Chen DQ; Wang M; Guo Y; Zhao YY
    Adv Clin Chem; 2018; 85():91-113. PubMed ID: 29655463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic biomarkers in kidney disease: issues in development and implementation.
    Mischak H; Delles C; Vlahou A; Vanholder R
    Nat Rev Nephrol; 2015 Apr; 11(4):221-32. PubMed ID: 25643662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary proteomics as a novel tool for biomarker discovery in kidney diseases.
    Wu J; Chen YD; Gu W
    J Zhejiang Univ Sci B; 2010 Apr; 11(4):227-37. PubMed ID: 20349519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application.
    Mischak H; Delles C; Klein J; Schanstra JP
    Adv Chronic Kidney Dis; 2010 Nov; 17(6):493-506. PubMed ID: 21044772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Searching for new biomarkers of renal diseases through proteomics.
    Konvalinka A; Scholey JW; Diamandis EP
    Clin Chem; 2012 Feb; 58(2):353-65. PubMed ID: 21980170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic approaches in kidney disease biomarker discovery.
    Fenton RA
    Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1817-F1821. PubMed ID: 30230371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis of urine from male dogs during early stages of tubulointerstitial injury in a canine model of progressive glomerular disease.
    Nabity MB; Lees GE; Dangott LJ; Cianciolo R; Suchodolski JS; Steiner JM
    Vet Clin Pathol; 2011 Jun; 40(2):222-36. PubMed ID: 21446987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in proteomic profiling of pediatric kidney diseases.
    Cummins TD; Korte EA; Bhayana S; Merchant ML; Barati MT; Smoyer WE; Klein JB
    Pediatr Nephrol; 2022 Oct; 37(10):2255-2265. PubMed ID: 35220505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics in Kidney Allograft Transplantation-Application of Molecular Pathway Analysis for Kidney Allograft Disease Phenotypic Biomarker Selection.
    Marx D; Metzger J; Olagne J; Belczacka I; Faguer S; Colombat M; Husi H; Mullen W; Gwinner W; Caillard S
    Proteomics Clin Appl; 2019 Mar; 13(2):e1800091. PubMed ID: 30680934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary proteomics: a tool to discover biomarkers of kidney diseases.
    Dihazi H; Müller GA
    Expert Rev Proteomics; 2007 Feb; 4(1):39-50. PubMed ID: 17288514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical application of urinary proteomics/peptidomics.
    Albalat A; Mischak H; Mullen W
    Expert Rev Proteomics; 2011 Oct; 8(5):615-29. PubMed ID: 21999832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein biomarkers in renal transplantation.
    Chakraborty A; Sarwal M
    Expert Rev Proteomics; 2018 Jan; 15(1):41-54. PubMed ID: 29106314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers.
    L'Imperio V; Smith A; Chinello C; Pagni F; Magni F
    Proteomics Clin Appl; 2016 Apr; 10(4):371-83. PubMed ID: 26642820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of phosphorylated MYL12B as a potential plasma biomarker for septic acute kidney injury using a quantitative proteomic approach.
    Wu F; Dong XJ; Li YY; Zhao Y; Xu QL; Su L
    Int J Clin Exp Pathol; 2015; 8(11):14409-16. PubMed ID: 26823757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics role in the search for improved diagnosis, prognosis and treatment of osteoarthritis.
    Ruiz-Romero C; Blanco FJ
    Osteoarthritis Cartilage; 2010 Apr; 18(4):500-9. PubMed ID: 20060947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic-based biomarker discovery for development of next generation diagnostics.
    Khalilpour A; Kilic T; Khalilpour S; Álvarez MM; Yazdi IK
    Appl Microbiol Biotechnol; 2017 Jan; 101(2):475-491. PubMed ID: 28013407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary Peptidomic Biomarkers in Kidney Diseases.
    Sirolli V; Pieroni L; Di Liberato L; Urbani A; Bonomini M
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31877774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometry-based proteomic quest for diabetes biomarkers.
    Shao S; Guo T; Aebersold R
    Biochim Biophys Acta; 2015 Jun; 1854(6):519-27. PubMed ID: 25556002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of urinary proteomics for the detection of biomarkers of kidney diseases.
    Jiang S; Wang Y; Liu Z
    Adv Exp Med Biol; 2015; 845():151-65. PubMed ID: 25355578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics in chronic kidney disease: The issues clinical nephrologists need an answer for.
    Spasovski G; Ortiz A; Vanholder R; El Nahas M
    Proteomics Clin Appl; 2011 Jun; 5(5-6):233-40. PubMed ID: 21538916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.